Drug developer Watson Pharmaceuticals Inc. said Wednesday its profit fell 11 percent in the third quarter as higher taxes and charges offset a revenue boost. Watson said profit declined to $63 million, or 55 cents per share, from $71.1 million, or 62 cents…

Email this Article
Add to del.icio.us
Add to digg
Add to Facebook




Watson Pharmaceuticals – Revenue – Business – Biotechnology and Pharmaceuticals – Pharmaceuticals

View original here:
Watson 3Q profit falls 11 percent on taxes, costs